These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20602602)

  • 1. Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome.
    El-Salhy M; Lomholt-Beck B; Hausken T
    Scand J Gastroenterol; 2010 Dec; 45(12):1435-9. PubMed ID: 20602602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome.
    El-Salhy M; Wendelbo IH; Gundersen D
    Mol Med Rep; 2013 Apr; 7(4):1241-4. PubMed ID: 23426642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance.
    Mazzawi T; El-Salhy M
    Int J Mol Med; 2016 May; 37(5):1247-53. PubMed ID: 26987104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of serum chromogranin A in diarrhoea predominant irritable bowel syndrome.
    Sidhu R; McAlindon ME; Leeds JS; Skilling J; Sanders DS
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):23-6. PubMed ID: 19337629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromogranin A cell density in the rectum of patients with irritable bowel syndrome.
    El-Salhy M; Mazzawi T; Gundersen D; Hausken T
    Mol Med Rep; 2012 Dec; 6(6):1223-5. PubMed ID: 22992886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome.
    El-Salhy M; Patcharatrakul T; Hatlebakk JG; Hausken T; Gilja OH; Gonlachanvit S
    Scand J Gastroenterol; 2017; 52(6-7):691-697. PubMed ID: 28346031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities.
    El-Salhy M; Hatlebakk JG; Hausken T
    World J Gastroenterol; 2015 Aug; 21(32):9577-87. PubMed ID: 26327765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal rectal endocrine cells in patients with irritable bowel syndrome.
    El-Salhy M; Gundersen D; Hatlebakk JG; Gilja OH; Hausken T
    Regul Pept; 2014 Jan; 188():60-5. PubMed ID: 24316398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of celiac disease in patients with irritable bowel syndrome.
    El-Salhy M; Lomholt-Beck B; Gundersen D
    Mol Med Rep; 2011; 4(3):403-5. PubMed ID: 21468583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome.
    El-Salhy M; Gilja OH; Gundersen D; Hatlebakk JG; Hausken T
    Gastroenterol Res Pract; 2014; 2014():462856. PubMed ID: 25028588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome.
    El-Salhy M; Vaali K; Dizdar V; Hausken T
    Dig Dis Sci; 2010 Dec; 55(12):3508-13. PubMed ID: 20300845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High chromogranin A cell density in the colon of patients with lymphocytic colitis.
    El-Salhy M; Lomholt-Beck B; Gundersen TD
    Mol Med Rep; 2011; 4(4):603-5. PubMed ID: 21584496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
    Bouchoucha M; Devroede G; Dorval E; Faye A; Arhan P; Arsac M
    Tech Coloproctol; 2006 Dec; 10(4):287-96. PubMed ID: 17115321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome.
    El-Salhy M; Gilja OH
    BMC Gastroenterol; 2017 Aug; 17(1):90. PubMed ID: 28764761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal Calprotectin and serum chromogranin A as potential biomarkers of irritable bowel syndrome symptom severity.
    Pletikosic S; Plavsic I; Hauser G; Tkalcic M
    Med Hypotheses; 2015 Sep; 85(3):339-42. PubMed ID: 26112162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
    Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
    Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M
    Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade inflammation in the rectum of patients with sporadic irritable bowel syndrome.
    El-Salhy M; Gundersen D; Hatlebakk JG; Hausken T
    Mol Med Rep; 2013 Apr; 7(4):1081-5. PubMed ID: 23417076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting.
    De Silva AP; Nandasiri SD; Hewavisenthi J; Manamperi A; Ariyasinghe MP; Dassanayake AS; Jewell DP; de Silva HJ
    Scand J Gastroenterol; 2012 Jun; 47(6):619-24. PubMed ID: 22486731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome.
    Mazzawi T; Gundersen D; Hausken T; El-Salhy M
    Mol Med Rep; 2014 Nov; 10(5):2322-6. PubMed ID: 25174455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.